Please Wait a Moment
X

Articles

21Sep

Reminder-Bio-Rad Geenius HIV 1/2 Implemented

21 Sep, 2020 | Return|

CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.

Read all about it on the Communication page by clicking this link: Communications

 

 

Related

Sample submission during the national blood shortage

Through communications with our clients, CTS is aware of the current national blood shortage. We rea...

Read More >

National Medical Laboratory Week from April 19th to April 25th

Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...

Read More >

Reminder-Revised Client Forms

 Just a reminder that the revised client forms implement today! Don't forget to toss your o...

Read More >

Reminder- Check flights and cargo hours for the 4th of July Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >
Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Long-time CTS Leader Josh Moon to Guide Operations as Chief Operating Officer

Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...

Read More >

Spotlight on CTS AABB Annual Meeting Abstract Posters

CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...

Read More >